IPG Photonics Corporation (IPGP) | The Buildout — AI Infrastructure
The Verdict
IPG Photonics develops and manufactures high-performance fiber lasers, fiber amplifiers, diode lasers, and laser-based systems. In the AI buildout, its lasers reach semiconductor capital equipment for lithography, metrology, and inspection, and they weld battery cells for stationary storage that supports data center power. The company is vertically integrated, designing and making most of its key components internally.
| Market Cap | — |
| Revenue (TTM) | $1.0B |
| Revenue Growth | +9.3% |
| EBITDA Margin (TTM) | 6.8% |
| Net Cash | $797M |
| Earnings Beats | 5 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Industrial Solutions was 85.7% of Q1 2026 revenue and grew 21% year over year, led by battery welding, cutting, marking, and cleaning.
- Book-to-bill was firmly above 1 for the second consecutive quarter, signaling demand momentum.
- Systems revenue grew 28.2% year over year, roughly twice the 14.0% growth of lasers and components.
- Advanced Solutions carries a $5 billion TAM, while Q1 2026 Advanced revenue was $37.9M, leaving a large disclosed market for conversion.
- Cash and short-term investments of $813M fund the $90–100M FY2026 CapEx budget, including the German fiber facility.
What We’re Watching
- Adjusted gross margin of 37.8% remains well below the mid-40s target, with no timeline disclosed.
- Tariffs are a ~150 bps headwind expected to persist through 2026; Q1 actual impact was ~160 bps year over year.
- Management flagged tougher H2 2026 comparisons against a strong H2 2025.
- Top-five customer concentration rose to 20% of Q1 sales from 16% in FY2025 and 13% in FY2024; one unnamed customer is 12% of receivables.
Thesis is strengthening but incomplete. Revenue is reaccelerating and bookings are above 1, but margin recovery remains gradual and customer concentration is rising. The open question is whether IPG can hold book-to-bill above 1 through tougher H2 comparisons while moving adjusted gross margin back toward the mid-40s target.
Earnings Beat
Q1 2026 revenue rose 16.6% year over year to $265.5M, above the high end of guidance. GAAP gross margin was 37.5% and adjusted gross margin 37.8%, down from 39.4% and 40.0% a year earlier respectively. Book-to-bill was firmly above 1 for the second consecutive quarter.
| Metric | Q1 FY2026 | Q4 FY2025 | Q1 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $266M | $274M | $228M | +16.5% |
| Gross margin | 37.5% | 36.1% | 39.4% | -190bps |
| EBITDA | $8M | $23M | $17M | −52.3% |
| EPS | $0.04 | $0.31 | $0.09 | −58.0% |
| Book-to-bill | Firmly above 1 | Above 1 | n/a | — |
| Emerging growth products % of revenue | 53% | 53% | n/a | — |
Total bookings were strong in the quarter with book-to-bill firmly above 1 for the second consecutive quarter.— Mark Gitin, CEO, 2026-05-05
Management tone: Management tone was confident but measured. The CEO emphasized strong demand, the second consecutive quarter above book-to-bill 1, and strategic progress, while the CFO stressed cost control, the ~150 bps tariff drag, underabsorbed costs, and tougher second-half comparisons.
Management Guidance
Management initiated Q2 2026 guidance of revenue $260 million to $290 million, adjusted gross margin 37% to 40%, adjusted operating expenses $92 million to $95 million, adjusted EPS $0.25 to $0.55, and adjusted EBITDA $32 million to $48 million. The margin guide includes an ongoing tariff impact of about 150 basis points.
Trajectory
Reported revenue returned to year-over-year growth, with Q1 FY2026 revenue up 16.6% to $265.5M. The gain came from Industrial Solutions, up 21.0% year over year, while Advanced Solutions declined 4.7%. Gross margin stabilized at 37.5% GAAP, up from 36.1% in the prior quarter but below 39.4% a year earlier; Q1 EBITDA margin compressed to 3.1% because of the $13.5M TRUMPF settlement and tariff/product-cost headwinds.
The Model
The model projects FY+1 revenue of $1,112M and EBITDA of $153M (13.8% margin). FY+2 revenue is projected at $1,250M with EBITDA of $198M (15.8% margin). Near-term revenue is anchored by two consecutive quarters of book-to-bill above 1, with the $260–290M Q2 guide implying continued year-over-year growth; FY+2 assumes margins keep recovering as pricing, cost reductions, and lower underabsorption take hold.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $1.0B | $1.1B | $1.2B |
| YoY Growth | — | +10.8% | +12.4% |
| EBITDA | $80M | $153M | $198M |
| EBITDA Margin | 8.0% | 13.8% | 15.8% |
Projections are the median of 5 independent model runs. The model’s revenue sits 2.9% above analyst consensus.
Management initiated Q2 2026 guidance of revenue $260 million to $290 million, adjusted gross margin 37% to 40%, adjusted operating expenses $92 million to $95 million, adjusted EPS $0.25 to $0.55, and adjusted EBITDA $32 million to $48 million. The margin guide includes an ongoing tariff impact of about 150 basis points.
What Could Go Right — and Wrong
- Book-to-bill stays above 1 for a third consecutive quarter and IPG quantifies bookings, extending the demand recovery.
- Adjusted gross margin reaches or sustains 40% or higher in the back half, confirming pricing and cost-reduction progress.
- A second named defense customer beyond Lockheed Martin converts, broadening the Crossbow revenue base.
- Semiconductor design wins with large equipment makers convert to production orders, making the direct AI link concrete.
- New medical product approvals arrive in 2026 and 2027 as stated, supporting another year of medical growth.
- Bookings fall back below 1 in Q2, making the two-quarter recovery look transitory.
- Adjusted gross margin remains in the upper 30s while tariffs and underabsorption persist; the mid-40s target fades.
- H2 comparison wall plus soft bookings produce a growth stall and margin disappointment simultaneously.
- The unnamed 12% accounts-receivable customer proves to be a concentrated cyclical account and slows.
- A disruption at the single-site diode or specialty fiber production line interrupts deliveries.
Looking Ahead
The next 12 months center on whether bookings convert into sustained revenue growth and margin expansion. Management initiated Q2 2026 guidance of $260–290M revenue and 37–40% adjusted gross margin, and flagged tougher second-half comparisons. Forward commitments include the Lockheed Martin $10M Crossbow follow-on beginning shipments in Q2 2026, new medical product approvals in 2026 and 2027, and semiconductor design-ins with large equipment makers. The German fiber manufacturing facility remains the main FY2026 CapEx driver behind the $90–100M budget.
- Q2 2026Q2 2026 earnings report — Tests $260–290M revenue guide, 37–40% adjusted gross margin, and book-to-bill trend.
- Q2 2026Crossbow follow-on shipments begin — Lockheed Martin $10M order begins shipping, delivered over multiple quarters.
- H2 2026H2 2026 comparison wall — Management flagged tougher comparisons against a strong H2 2025.
- 2026Medical product approvals — Management expects several new product approvals and introductions in 2026.
- 2026German fiber facility CapEx ramp — FY2026 CapEx budget is $90–100M, with Q1 at $16M due to facility timing.
- 2027Further medical product introductions — Management said additional new product introductions are expected in 2027.
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $977M | $1.0B | $1.0B | +2.7% |
| Gross Margin | 34.5% | 38.1% | 37.6% | +362bps |
| EBITDA | −$147M | $80M | $3.1B | +154.5% |
| EBITDA Margin | -15.0% | 8.0% | 6.8% | +2,300bps |
| Net Income | −$182M | $31M | $29M | +117.2% |
| Free Cash Flow | $149M | −$4M | $1.7B | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)37.6%
- EBITDA Margin (TTM)6.8%
- Net Margin (TTM)2.8%
- ROIC0.2%
- FCF Conversion-19.6%
- SBC / Revenue0.9%
The Company
IPG Photonics develops, manufactures, and sells high-performance fiber lasers, fiber amplifiers, diode lasers, and laser-based systems used in materials processing, medical, and advanced applications. The 10-K lists products from continuous wave lasers up to 125 kW through ultrafast and hybrid lasers, plus the CROSSBOW counter-UAS solution. Its lasers reach AI infrastructure indirectly: semiconductor lithography, metrology, and inspection equipment, and battery welding for stationary storage supporting data center power.
IPG is vertically integrated, designing and manufacturing most key components internally, including semiconductor diodes, specialty optical fibers, and optical components. The 10-K identifies manufacturing sites in Burbach, Germany for optical fiber and final assembly; Oxford, Massachusetts for diodes; Marlborough, Massachusetts; and Davenport, Iowa for systems integration. On the Q1 2026 call, management introduced a two-bucket reporting view: Industrial Solutions for cutting, welding, cleaning, marking and additive manufacturing, and Advanced Solutions for medical, defense, micromachining, semiconductor manufacturing, and other applications.
Business Segments
Competitive Landscape
The 10-K names competitors in fiber lasers and other lasers, including Coherent, JPT Opto-Electronics, Laserline, Lumentum, Maxphotonics, MKS Instruments, nLight, Trumpf, and Wuhan Raycus. Management describes IPG's differentiation as the combination of adjustable-mode beam lasers, advanced beam delivery, and real-time process monitoring, and says IPG's high-power single-mode lasers are the strongest for Crossbow.
- Named as a competitor in the 10-K.
- nLight, Inc.Named as a competitor in the 10-K.
- MKS Instruments, Inc.Named as a competitor in the 10-K.
- Trumpf GmbH + Co. KG10-K competitor; IPG settled worldwide patent litigation with TRUMPF Laser- und Systemtechnik SE for $13.5M plus a license.
- Named as a competitor in the 10-K.
Supply Chain
IPG is vertically integrated and sits between limited-source component suppliers and industrial, semiconductor, defense, and medical laser customers. The 10-K discloses dependence on internal production and outside single or limited-source suppliers for key components and raw materials.